Back
Vanda Pharmaceuticals Stock Price Chart
Top investors are buying this "unlisted" stock
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.
Sell
30
VNDA
Vanda Pharmaceuticals
Last Price:
$4.17
Seasonality Move:
84.65%
7 Day Trial
ALL ACCESS PASS
$
7
Spencer Rascoff co-founded Zillow, scaling it to a $16B valuation. But everyday investors couldn't invest until the IPO, missing early gains.
This is a paid advertisement for Pacaso's Regulation A offering. Please read the offering circular and related risks at invest.pacaso.com.-
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and VNDA is experiencing slight buying pressure.
Vanda Pharmaceuticals Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.1 | Sell |
| 20-day SMA: | 4.28 | Sell |
| 50-day SMA: | 4.49 | Sell |
| 200-day SMA: | 4.77 | Sell |
| 8-day EMA: | 4.08 | Sell |
| 20-day EMA: | 4.22 | Sell |
| 50-day EMA: | 4.39 | Sell |
| 200-day EMA: | 4.69 | Sell |
Vanda Pharmaceuticals Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.13 | Sell |
| Relative Strength Index (14 RSI): | 34.55 | Sell |
| Chaikin Money Flow: | 337298 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (4.08 - 4.46) | Sell |
| Bollinger Bands (100): | (4.28 - 4.82) | Sell |
Vanda Pharmaceuticals Technical Analysis
| May 2 | May 5 | May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 02 | 05 | 06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Vanda Pharmaceuticals Stock
Is Vanda Pharmaceuticals Stock a Buy?
-
Vanda Pharmaceuticals share price is 3.93 while VNDA 8-day simple moving average is 4.10, which is a Sell signal.
-
The stock price of VNDA is 3.93 while Vanda Pharmaceuticals 20-day SMA is 4.28, which makes it a Sell.
-
Vanda Pharmaceuticals 50-day simple moving average is 4.49 while VNDA share price is 3.93, making it a Sell technically.
-
VNDA stock price is 3.93 and Vanda Pharmaceuticals 200-day simple moving average is 4.77, creating a Sell signal.
VNDA Technical Analysis vs Fundamental Analysis
Sell
30
Vanda Pharmaceuticals (VNDA)
is a Sell
Is Vanda Pharmaceuticals a Buy or a Sell?
-
Vanda Pharmaceuticals stock is rated a SellThe current Vanda Pharmaceuticals [VNDA] share price is $3.93. The Score for VNDA is 30, which is 40% below its historic median score of 50, and infers higher risk than normal.
Vanda Pharmaceuticals Stock Info
Market Cap:
231.6M
Price in USD:
3.93
Share Volume:
671.3K
Vanda Pharmaceuticals 52-Week Range
52-Week High:
6.75
52-Week Low:
3.81
Sell
30
Vanda Pharmaceuticals (VNDA)
is a Sell
Vanda Pharmaceuticals Share Price Forecast
-
What is the Vanda Pharmaceuticals stock price today?The Vanda Pharmaceuticals stock price is 3.93 USD today.
-
Will VNDA stock go up or go down?Vanda Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators
-
Is Vanda Pharmaceuticals overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Vanda Pharmaceuticals is overvalued.
Is Vanda Pharmaceuticals Stock a Buy?
-
Vanda Pharmaceuticals share price is 3.93 while VNDA 8-day exponential moving average is 4.08, which is a Sell signal.
-
The stock price of VNDA is 3.93 while Vanda Pharmaceuticals 20-day EMA is 4.22, which makes it a Sell.
-
Vanda Pharmaceuticals 50-day exponential moving average is 4.39 while VNDA share price is 3.93, making it a Sell technically.
-
VNDA stock price is 3.93 and Vanda Pharmaceuticals 200-day simple moving average is 4.69, creating a Sell signal.
Technical Analysis of Vanda Pharmaceuticals
Should I short Vanda Pharmaceuticals stock?
-
VNDA Moving Average Covergence Divergence (MACD) indicator is -0.13, suggesting Vanda Pharmaceuticals is a Sell
-
Vanda Pharmaceuticals Relative Strength Index (RSI) is 34.55, which suggest Vanda Pharmaceuticals is oversold
-
The Bollinger Bands (25) for Vanda Pharmaceuticals is (4.08 - 4.46), which suggest Vanda Pharmaceuticals is a Sell
-
The Bollinger Bands (100) for Vanda Pharmaceuticals is (4.28 - 4.82), which suggest Vanda Pharmaceuticals is a Sell
* Vanda Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.